Compare NATL & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NATL | IRTC |
|---|---|---|
| Founded | 2023 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.7B |
| IPO Year | 2023 | 2016 |
| Metric | NATL | IRTC |
|---|---|---|
| Price | $47.16 | $119.38 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 16 |
| Target Price | $50.20 | ★ $171.33 |
| AVG Volume (30 Days) | ★ 750.1K | 453.8K |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 73.98 | 61.71 |
| EPS | ★ 1.15 | N/A |
| Revenue | ★ $4,354,000,000.00 | $747,138,000.00 |
| Revenue This Year | $2.59 | $19.40 |
| Revenue Next Year | $4.15 | $16.65 |
| P/E Ratio | $40.70 | ★ N/A |
| Revenue Growth | 0.86 | ★ 26.24 |
| 52 Week Low | $33.31 | $100.70 |
| 52 Week High | $48.50 | $210.01 |
| Indicator | NATL | IRTC |
|---|---|---|
| Relative Strength Index (RSI) | 64.65 | 63.25 |
| Support Level | $45.40 | $113.82 |
| Resistance Level | $48.23 | $125.38 |
| Average True Range (ATR) | 0.48 | 3.89 |
| MACD | 0.17 | 1.44 |
| Stochastic Oscillator | 97.46 | 96.12 |
NCR Atleos Corp is a financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers, and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels, all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware, and its proprietary Allpoint network. Atleos manages its operations in the following segments: Self-Service Banking, which generates maximum revenue, Network, and Telecommunications and Technology. Geographically, it derives maximum revenue from the U.S.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.